In the BioHarmony Drug Report Database
Tyzeka (telbivudine) is a small molecule pharmaceutical. Telbivudine was first approved as Tyzeka on 2006-10-25. It is used to treat chronic hepatitis b and hepatitis b in the USA. Sebivo, tyzeka’s patent is valid until 2023-09-11 (FDA).
Image (chem structure or protein)